PHARMACOLOGY FACULTY
Y.W. Francis Lam
 
 
Selected Publications
  • Cavallari, L. and Lam, YWF. (2014) Pharmacogenetics. In: Pharmacotherapy: A Pathophysiologic Approach DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (ed). 9th edition. McGraw-Hill, New York, New York. 2014, complete chapter available online, p 75-94, at www.pharmacotherapyonline.com with learning objectives and other resources.
  • Lam, YWF. and Cavallari, L. (2013) Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications. In: Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. Lam YWF, Cavallari L (ed). Elsevier, Inc. 2013,1-44.
  • Lam, YWF. (2011) Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity. Pharmacotherapy: A Pathophysiologic Approach 8th edition 2011; 705-716.
  • Cavallari, L. and Lam, YWF. (2011) Pharmacogenetics. Pharmacotherapy: A Pathophysiologic Approach 8th edition 2011; 17 and available online.

Y.W. Francis Lam

Professor of Pharmacology

Associate Professor of Medicine
Clinical Associate Professor & James O. Burke Endowed Centennial Fellow in Pharmacy,
Univ. of Texas at Austin
Pharm.D., University of Minnesota

Office: 210-567-8355
Email: lamf@uthscsa.edu

 
 

Reserach Interests

• drug metabolism • clinical pharmacology
• pharmacokinetics                     • pharmacogenetics
 

Research Activities

Significant variability in efficacy and toxicity of medications among patients is largely attributed to innate differences in their capacity to eliminate and react to medications. Dr. Lam has studied how ethicity and genetic differences affect disposition and response to psychotherapeutic drugs. This has translated to improved understanding of the biological basis for why patients require different doses to elicit appropriate responses, particularly Asians. Dr. Lam’s earlier findings suggested a genetic basis for variation in drug metabolism and response in Mexican Americans in San Antonio. His current focus is whether variation in genes that encode enzymes, transporters, and targets in Hispanics can be utilized for personalized cancer therapy, and is working with CTRC tinvestigators to integrate pharmacogenomics into anticancer drug development.


• Accomplishments, Awards and Honors •

2016 Presidential Teaching Excellence Award - UTHSCSA - March 2016


2015 School of Health Professions Teaching Excellence Award - UTHSCSA - Nov 2015


2015 University of Texas System Regents' Outstanding Teaching Award - Aug 2015


2014 Dental Faculty Assembly Teaching Excellence Award - UTHSCSA - May 2014

 

• Appointments, Boards, Committees and Memberships •

UTHSCSA Faculty Senate - 9/2015 thru 9/2018


Co-Leader for Human Health and Disease Track, New preclinical curriculum for UTHSCSA DDS program


Editorial Board Member - Current Pharmacogenomics and Personalized Medicine